RecruitingACTRN12609000860268

Madu tualang' honey as prophylaxis against febrile neutropenia in patients with haematological malignancy

In neutropenic patients with haematological malignancy, does the use of madu tualang honey lead to less febrile neutropenia compared to oral ciprofloxacin: Open, Randomised, Controlled, Two-Period Cross-Over study


Sponsor

Universiti Sains Malaysia

Enrollment

135 participants

Start Date

Aug 5, 2009

Study Type

Interventional

Conditions

Summary

Patient receiving myeloablative chemotherapy are at risk of developing febrile neutropenia (FN) which is an oncology emergency. Most FN are microbilogically negative but infection are mainly opportunistic infection arising from the gastrointestinal tract. Chemotherapy leads to mucosal injury besides the marked drop in peripheral white cell count. Ciprofloxacin has been used as a selective gut decontamination to reduce the amount of gut flora. Honey has been shown to have both antimicrobial activiti as well as mucosal protectation. Uncontrolled study also showed that honey shortened period of neutropenia. We do not know if this is due to true accelerated marrow rejuvenation or that the level of chemotheray was depressed following drug-honey interaction. 'Madu tualang' is a local honey product which is being studied if the above research question can be answered in controlled clinical trial.


Eligibility

Sex: Both males and femalesMin Age: 12 Yearss

Inclusion Criteria3

  • Confirmed to suffer from blood cancer and Plan to receive at least 2 cycles of same chemotherapy regime.
  • Functional status of European Cooperative Oncology Group (ECOG) score of 3 and better.
  • Consented and signed the consent form.

Exclusion Criteria9

  • history of allergy to ciprofloxacin.
  • history of allergy to honey product.
  • undergoing high dose chemotherapy for stem cell transplantation.
  • serius diabetes requiring intravenous insulin infusion.
  • pregnant or breast-feeding.
  • already ommenced on antibiotics for other than prophylactic indications prior to chemotherapy making the use of ciprofloxacin unnecessary.
  • Impaired renal function (serum creatinine > 300 micromol/L).
  • Impaired liver excretory function (serum bilirubin > 85 micromol/L).
  • Impaired liver cell integrity (alanin transaminase [ALT] > 5x upper limit of normal

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Madu tualang honey, 20 gm twice a day consumed orally till recovery of neutropenia, i.e absolute neutrophil count above 1.0 x 10^6/liter

Madu tualang honey, 20 gm twice a day consumed orally till recovery of neutropenia, i.e absolute neutrophil count above 1.0 x 10^6/liter


Locations(1)

Kota Bharu, Malaysia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000860268


Related Trials